| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/10/2003 | US20030130243 Hormone replacement therapy |
| 07/10/2003 | US20030129732 Chromated copper arsenate (CCA) preservatives; inoculation |
| 07/09/2003 | EP1324762A2 Separation of cresol from mare's urine |
| 07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
| 07/09/2003 | CN1113893C Method for extracting hytosterol from vegetable oil asphalt or tall oil asphalt |
| 07/03/2003 | WO2003053990A1 Phosphoric acid isomerization of a 5(10),9(11)-diene steroid to the corresponding 4,9-diene steroid |
| 07/03/2003 | WO2002094849A3 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 07/03/2003 | CA2467741A1 Phosphoric acid isomerization of a 5(10),9(11)-diene steroid to the corresponding 4,9-diene steroid |
| 07/02/2003 | EP1322660A2 17alpha-fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 07/02/2003 | EP1322336A1 Method of increasing testosterone and related steroid concentrations in women |
| 07/02/2003 | EP0779810B1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 07/01/2003 | CA2089194C Steroid derivatives |
| 06/24/2003 | US6583130 C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds |
| 06/19/2003 | US20030114431 Monounsaturated fatty acids of at least 20 carbon atoms and perhydrocyclopentanophenanthrene nucleus combination molecules and their use as weight-loss agents |
| 06/19/2003 | US20030113800 Detecting steroids and peptides with microarrays |
| 06/17/2003 | US6579864 Arthritic diseases and/or autoimmune diseases |
| 06/12/2003 | US20030109728 Phosphoric acid isomerization of A 5 (10), 9 (11) - diene steroid to the corresponding 4, 9-diene steriod |
| 06/12/2003 | US20030109721 Oxidation of mestanolone; hydroxylation; reduction |
| 06/12/2003 | US20030109513 B-ring estratrienes |
| 06/11/2003 | EP1317270A1 Exemestane for the treatment of oestrogen-dependent cancers |
| 06/11/2003 | CN1423560A Male contraceptive formulation comprising norethisterone |
| 06/05/2003 | WO2003045972A1 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATES FOR THE PRODUCTION THEREOF, AND USE OF SAID 17α-ALKYL-17β-OXY-ESTRATRIENES FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS |
| 06/05/2003 | WO2003045397A1 Dosage regimen and pharmaceutical composition for emergency contraception |
| 06/04/2003 | EP1315502A1 Method for treating erectile dysfunction and increasing libido in men |
| 06/04/2003 | EP0973790B1 Estra-5(10),7-dienes with estrogenic activity |
| 06/04/2003 | EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 05/28/2003 | EP0717626B1 Preparation for substitution therapy, containing at least one progestogen and at least one extrogen |
| 05/27/2003 | US6569842 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 05/22/2003 | WO2002076390A3 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 05/22/2003 | US20030096800 Estrogenic compounds as anti-mitotic agents |
| 05/22/2003 | US20030096799 Novel 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
| 05/21/2003 | EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders |
| 05/21/2003 | CN1108800C Combined hormonal contraception pharmaceutical preparation |
| 05/20/2003 | US6566542 Such as 17-alpha-fluoro-11-beta-(4-(2-(1-piperidinyl) ethoxy) phenyl)-estra-1,3,5(10)-trien-3-ol for treatment of osteoporosis and cardiovascular protection; side effect reduction; provides alternative to estradiol |
| 05/15/2003 | US20030092692 Alzheimer's and parkinson's disease |
| 05/15/2003 | US20030092096 Process for producing sterol or stanol esters by enzymatic transesterification in solvent and water free media |
| 05/14/2003 | EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv |
| 05/14/2003 | CN1418101A Method of increasing alertness by administration of vomeropherin and vomeropherin-emitting alarm device |
| 05/08/2003 | US20030087886 Orally active androgens |
| 05/07/2003 | EP1307471A1 16alpha-methyl or ethyl substituted estrogens |
| 05/07/2003 | EP1307205A2 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration |
| 05/07/2003 | EP0752861B1 use of STEROID 5-ALPHA-REDUCTASE INHIBITORS in the manufacture of a medicament for TREATING CARDIOVASCULAR DISEASE |
| 05/07/2003 | CN1415624A Technique for synthesizing the exemestane |
| 05/06/2003 | CA2172816C Alkylating agent and 1,4-addition process of an alkyl group onto an alpha, beta-unsaturated ketone compound |
| 05/02/2003 | EP1121375B1 High purity compound (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 05/02/2003 | EP0811006B1 Benzopyran-containing compounds and method for their use |
| 05/01/2003 | US20030083323 Oral use of dehydroepiandrosterone and some of its derivatives as pigmentation regulators |
| 05/01/2003 | US20030083231 Used of androstane derivatives in treatment of conditions such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy |
| 04/29/2003 | US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery |
| 04/24/2003 | WO2003033518A1 Steroidal compounds for inhibiting steroid sulphatase |
| 04/24/2003 | WO2003033516A1 8β -SUBSTITUTED-11β -ARYL-ESTRA-1,3,5(10)-TRIENE DERIVATIVES |
| 04/24/2003 | WO2003032961A2 Methods for preventing and treating bone loss with steroid compounds |
| 04/24/2003 | CA2463142A1 Methods for preventing and treating bone loss with steroid compounds |
| 04/23/2003 | EP1304334A1 Novel antiandrogenic agent |
| 04/23/2003 | EP1304333A2 6,7-Oxygenated steroids and uses related thereto |
| 04/23/2003 | EP0956022B1 Hormonal composition consisting of an oestrogen compound and of a progestational compound |
| 04/22/2003 | US6552010 Treatment of SLE with dehydroepiandrosterone |
| 04/17/2003 | WO2003020294A8 Aromatase marking |
| 04/17/2003 | WO2003000271A3 System and method for the large scale labeling of compounds with radiohalogens |
| 04/17/2003 | US20030073640 Novel compositions for the delivery of negatively charged molecules |
| 04/16/2003 | EP1090027B1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/15/2003 | CA2084775C Method of treating human prostatic adenocarcinoma |
| 04/10/2003 | WO2003029269A1 Solvent extraction process |
| 04/10/2003 | US20030069217 Methods of prevention and treatment of ischemic damage |
| 04/10/2003 | US20030069215 Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
| 04/10/2003 | CA2461928A1 Solvent extraction process |
| 04/09/2003 | CN1409724A 雌二醇轭合物和其用途 Estradiol conjugates and uses thereof |
| 04/09/2003 | CN1409635A Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/08/2003 | US6544971 Alarm device especially for detecting fires, unauthorized entry or sleep apnea, or the presence of CO, CH4, propane or radon |
| 04/03/2003 | WO2003026589A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 04/03/2003 | WO2003026568A2 Androstanes as androgen receptor modulators |
| 04/03/2003 | US20030065017 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists / antagonists, estrogens and progestins |
| 04/03/2003 | US20030064973 Sexual disorders |
| 04/03/2003 | US20030064492 Nucleotide sequences for use as tool in human therapeutics and diagnostics |
| 04/03/2003 | CA2459943A1 Androstanes as androgen receptor modulators |
| 04/02/2003 | EP1298115A1 Process for the preparation of polyhydric alcohols |
| 04/02/2003 | EP0738157B1 Contrast media for x-ray and magnetic resonance imaging |
| 04/02/2003 | CN1407896A Exemestane for first-line treatment of breast cancer |
| 04/01/2003 | US6541465 Orally active androgens |
| 04/01/2003 | US6541463 Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use |
| 03/27/2003 | US20030060425 Immune modulation method using steroid compounds |
| 03/27/2003 | US20030059451 Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin |
| 03/26/2003 | EP1295871A1 Vitamin d derivatives |
| 03/26/2003 | EP1294446A2 Alkyl ether modified polycyclic compounds having a terminal phenol as cell protecting agents |
| 03/26/2003 | EP1294382A1 7-hydroxyepiandrosterone having neuroprotective activity |
| 03/20/2003 | WO2003022864A1 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 03/20/2003 | WO2002026760A3 Separation of cresol from mare's urine |
| 03/20/2003 | US20030055274 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 03/20/2003 | US20030055029 Combbretastatin a-4 as an anti-angiogenic agent |
| 03/20/2003 | US20030054021 7-oxo-DHEA compounds for treating keratinous conditions/afflictions |
| 03/19/2003 | CN1404394A Pharmaceutical compositions containing steroidal structures and uses thereof |
| 03/13/2003 | WO2003020294A1 Aromatase marking |
| 03/13/2003 | WO2003020284A1 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
| 03/13/2003 | WO2002042319A3 2-substituted estrogens as antiangiogenic agents |
| 03/13/2003 | US20030050293 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 03/13/2003 | US20030050286 Steroids with a cyclohexene moiety are oxidized to the corresponding alpha, beta-unsaturated ketone that is converted to the corresponding vicinal diol using a hydroborating reagent followed by oxidative workup |
| 03/12/2003 | CN1402734A 3-methylene steroid deriv. |
| 03/06/2003 | WO2003018529A1 Monounsaturated fatty acids of at least 20 carbon atoms and perhydrocyclopentanophenanthrene nucleus combination molecules and their use as weight-loss agents |